CVRX CVRx, Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$1,55
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,5052-Wochen-Tief
$11,3052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$41M
P/E (TTM)
-0.8
EPS (TTM)
$-1.97
Umsatz (TTM)
$61M
Ihre Abzeichen
52W-Spanne
$2–$11
Analystenbewertung
BUY
Kursziel
$5
P/E
-0.8
ROE
-133.4%
Nettogewinnmarge
-84.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CVRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.55
Marktkapitalisierung (MRQ)
$41M
P/E (TTM)
-0.8
EPS (TTM)
$-1.97
Umsatz (TTM)
$61M
ROE (TTM)
-133.4%
Verschuldungsgrad (MRQ)
2.9
52W-Spanne
$2–$11
CVRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über CVRx, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealth Care
BrancheHealth Care
Mitarbeiter223
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$57M2020-12-31 → 2025-12-31
EPS$-2.042021-12-31 → 2025-12-31
Freier Cashflow$-41M2021-12-31 → 2025-12-31
Nettogewinnmarge-84.9%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CVRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -0.85-Jahres-Durchschnitt ≈-7.2 | ≈-7.2 | · | · | |
| P/S (TTM) | 0.75-Jahres-Durchschnitt ≈12.4 | ≈12.4 | 2.2 | Fairer Wert | |
| K/B (MRQ) | 2.15-Jahres-Durchschnitt ≈4.6 | ≈4.6 | 3.8 | Überbewertet | |
| EV / EBITDA | -0.35-Jahres-Durchschnitt ≈-6.4 | ≈-6.4 | · | · | |
| Kurs / FCF (TTM) | -1.05-Jahres-Durchschnitt ≈-9.3 | ≈-9.3 | · | · | |
| Kurs / Cashflow (TTM) | -1.05-Jahres-Durchschnitt ≈-9.5 | ≈-9.5 | · | · | |
| EV / Revenue (EV / Umsatz) | 0.35-Jahres-Durchschnitt ≈8.8 | ≈8.8 | · | · | |
| EV / FCF | -0.45-Jahres-Durchschnitt ≈-7.1 | ≈-7.1 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.05-Jahres-Durchschnitt ≈4.6 | ≈4.6 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CVRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 86.9%5-Jahres-Durchschnitt ≈80.6% | ≈80.6% | 37.9% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | -79.5%5-Jahres-Durchschnitt ≈-140.9% | ≈-140.9% | -18.1% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -90.5%5-Jahres-Durchschnitt ≈-140.9% | ≈-140.9% | -17.5% | Schwach | |
| Vorgewinnmarge (TTM) | -84.9%5-Jahres-Durchschnitt ≈-165.8% | ≈-165.8% | -11.6% | Schwach | |
| Nettogewinnmarge (TTM) | -84.9%5-Jahres-Durchschnitt ≈-166.1% | ≈-166.1% | -50.8% | Unterdurchschnittlich | |
| ROA (TTM) | -49.1%5-Jahres-Durchschnitt ≈-39.4% | ≈-39.4% | -13.7% | Schwach | |
| ROE (TTM) | -133.4%5-Jahres-Durchschnitt ≈-62.9% | ≈-62.9% | -81.1% | Schwach | |
| ROIC | -57.7%5-Jahres-Durchschnitt ≈-40.6% | ≈-40.6% | -16.7% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CVRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 2.95-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 1.8 | Überdurchschnittlich | |
| Liquiditätsgrad (MRQ) | 8.05-Jahres-Durchschnitt ≈14.9 | ≈14.9 | 2.7 | Starke Liquidität | |
| Quick Ratio | 6.55-Jahres-Durchschnitt ≈13.6 | ≈13.6 | 1.9 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 2.95-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 2.9 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CVRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 10.4%5-Jahres-Durchschnitt ≈60.7% | ≈60.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 36.1%5-Jahres-Durchschnitt ≈60.2% | ≈60.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 56.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CVRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.55-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.7 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 0.75-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 2.3 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 5.75-Jahres-Durchschnitt ≈6.0 | ≈6.0 | 5.8 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$254.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
1.1%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $-0.53 | $-0.53 | 0.90% |
| 31. März 2026 | $-0.50 | $-0.51 | 2.8% | |
| 31. Dezember 2025 | $-0.46 | $-0.45 | -2.8% | |
| 30. September 2025 | $-0.49 | $-0.51 | 4.2% | |
| 30. Juni 2025 | $-0.57 | $-0.53 | -7.5% | |
| 31. März 2025 | $-0.53 | $-0.58 | 8.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $57M | $51M | $39M | $22M | $13M | $6M | |
| Cost of Revenue | $8M | $8M | $6M | $5M | $4M | $1M | |
| Gross Profit | $48M | $43M | $33M | $17M | $9M | $5M | |
| R&D Expense | $11M | $11M | $12M | $10M | $8M | $6M | |
| SG&A Expense | $88M | $91M | $65M | $50M | $28M | $10M | |
| Operating Expenses | $100M | $102M | $76M | $60M | $35M | $16M | |
| Operating Income | $-51M | $-59M | $-43M | $-43M | $-26M | $-12M | |
| Interest Expense | · | · | $2M | $165.0K | $2M | $2M | |
| Other Non-op | $4M | $4M | $4M | $1M | $-15M | $-40.0K | |
| Pretax Income | $-53M | $-60M | $-41M | $-41M | $-43M | $-14M | |
| Income Tax | $-18.0K | $55.0K | $147.0K | $109.0K | $91.0K | $85.0K | |
| Net Income | $-53M | $-60M | $-41M | $-41M | $-43M | $-14M | |
| EPS (Basic) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · | |
| EPS (Diluted) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · | |
| Shares (Basic) | 26,084,709 | 22,596,229 | 20,754,375 | 20,532,838 | 10,360,054 | · | |
| Shares (Diluted) | 26,084,709 | 22,596,229 | 20,754,375 | 20,532,838 | 10,360,054 | · | |
| EBITDA | $-51M | $-59M | $-43M | $-43M | $-26M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $76M | $106M | $91M | $106M | $142M | $59M | |
| Receivables | $11M | $9M | $8M | $6M | $3M | $1M | |
| Inventory | $12M | $12M | $11M | $7M | $4M | $3M | |
| Prepaid Expense | $3M | $3M | $3M | $4M | $3M | $605.0K | |
| Current Assets | $102M | $130M | $112M | $123M | $151M | $64M | |
| PP&E (Net) | $2M | $3M | $2M | $2M | $1M | $410.0K | |
| PP&E (Gross) | $6M | $6M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $26.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | |
| Total Assets | $105M | $133M | $115M | $125M | $153M | $65M | |
| Accounts Payable | $4M | $3M | $2M | $2M | $510.0K | $483.0K | |
| Accrued Liabilities | $9M | $8M | $6M | $6M | $5M | $4M | |
| Current Liabilities | $13M | $11M | $8M | $8M | $6M | $8M | |
| Capital Leases | $638.0K | $877.0K | $1M | $117.0K | $0 | · | |
| Other Non-current Liabilities | $2M | $1M | $1M | $805.0K | $681.0K | $777.0K | |
| Total Liabilities | $65M | $62M | $39M | $16M | $7M | $28M | |
| Long-term Debt | · | · | · | · | · | $19M | |
| Total Debt | $50M | $49M | $29M | $7M | $0 | · | |
| Common Stock | $263.0K | $253.0K | $209.0K | $207.0K | $204.0K | $4.0K | |
| Retained Earnings | $-591M | $-537M | $-477M | $-436M | $-395M | $-352M | |
| AOCI | $-203.0K | $-206.0K | $-207.0K | $-207.0K | $-198.0K | $-190.0K | |
| Stockholders' Equity | $39M | $71M | $76M | $109M | $146M | $-293M | |
| Liabilities + Equity | $105M | $133M | $115M | $125M | $153M | $65M | |
| Shares Outstanding | 26,311,607 | 25,324,684 | 20,879,199 | 20,663,736 | 20,399,337 | 360,412 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $19M | $6M | $4M | $2M | $132.0K | |
| Operating Cash Flow | $-40M | $-39M | $-39M | $-43M | $-28M | $-16M | |
| CapEx | $580.0K | $1M | $591.0K | $685.0K | $1M | $311.0K | |
| Investing Cash Flow | $-580.0K | $-1M | $-591.0K | $-685.0K | $-1M | $-311.0K | |
| Net Debt Issued | · | · | · | $0 | $-21M | · | |
| Stock Issued | $9M | $33M | $0 | $0 | $133M | $0 | |
| Net Stock Activity | $9M | $33M | · | $0 | $133M | · | |
| Financing Cash Flow | $11M | $56M | $24M | $7M | $112M | $50M | |
| Net Change in Cash | $-30M | $15M | $-16M | $-36M | $83M | $33M | |
| Free Cash Flow | $-41M | $-41M | $-40M | $-43M | $-29M | · | |
| Levered FCF | · | · | $-41M | $-44M | $-31M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% | · | |
| Operating Margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% | · | |
| Net Margin | -94.1% | -116.9% | -104.8% | -184.4% | -330.4% | · | |
| Pretax Margin | -94.1% | -116.8% | -104.5% | -183.9% | -329.8% | · | |
| EBITDA Margin | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% | · | |
| ROA | -44.8% | -48.2% | -34.3% | -29.9% | -39.6% | · | |
| ROE | -109.6% | -88.0% | -51.9% | -36.4% | -28.5% | · | |
| ROIC | -57.7% | -49.5% | -41.1% | -36.8% | -17.8% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | 12.1 | 14.3 | 15.2 | 25.6 | · | |
| Quick Ratio | 6.5 | 10.7 | 12.5 | 13.8 | 24.5 | · | |
| Debt / Equity | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 | · | |
| LT Debt / Equity | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 | · | |
| Interest Coverage | · | · | -24.0 | -257.7 | -11.7 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.2 | 0.1 | · | |
| Inventory Turnover | 0.7 | 0.7 | 0.7 | 0.9 | 1.0 | · | |
| Receivables Turnover | 5.7 | 6.1 | 6.0 | 5.6 | 6.8 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.49 | $2.81 | $3.64 | $5.29 | $7.16 | · | |
| Revenue / Share | $2.17 | $2.27 | $1.89 | $1.09 | · | · | |
| Cash Flow / Share | $-1.54 | $-1.73 | $-1.88 | $-2.08 | · | · | |
| Cash / Share | $2.88 | $4.18 | $4.34 | $5.15 | $6.96 | · | |
| EPS (TTM) | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.4% | 30.5% | 74.9% | 72.4% | 115.4% | · | |
| Revenue CAGR 3Y | 36.1% | 57.9% | 86.6% | · | · | · | |
| Revenue CAGR 5Y | 56.4% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $57M | $51M | $39M | $22M | $13M | · | |
| Net Income TTM | $-53M | $-60M | $-41M | $-41M | $-43M | · | |
| Market Cap | $187M | $321M | $656M | $379M | $249M | · | |
| Enterprise Value | $161M | $264M | $595M | $279M | $107M | · | |
| P/E | -3.5 | -4.8 | -15.8 | -9.1 | -2.9 | · | |
| P/S | 3.3 | 6.3 | 16.7 | 16.9 | 19.1 | · | |
| P/B | 4.8 | 4.5 | 8.6 | 3.5 | 1.7 | · | |
| P / Tangible Book | 4.8 | 4.5 | 8.6 | 3.5 | 1.7 | · | |
| P / Cash Flow | -4.7 | -8.2 | -16.8 | -8.9 | -9.0 | · | |
| P / FCF | -4.6 | -7.9 | -16.6 | -8.7 | -8.6 | · | |
| EV / EBITDA | -3.1 | -4.4 | -13.8 | -6.6 | -4.1 | · | |
| EV / FCF | -3.9 | -6.5 | -15.0 | -6.4 | -3.7 | · | |
| EV / Revenue | 2.8 | 5.2 | 15.1 | 12.4 | 8.2 | · | |
| Earnings Yield | -28.7% | -20.9% | -6.3% | -11.0% | -34.0% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $15M | $16M | $15M | $14M | $12M | $15M | $13M | $12M | $11M | $11M | $11M | $10M | $8M | $7M | $6M | |
| Cost of Revenue | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | |
| Gross Profit | $14M | $13M | $14M | $13M | $11M | $10M | $13M | $11M | $10M | $9M | $10M | $9M | $8M | $7M | $6M | $5M | |
| R&D Expense | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $2M | |
| SG&A Expense | $24M | $22M | $22M | $22M | $23M | $21M | $20M | $22M | $21M | $28M | $17M | $16M | $16M | $15M | $14M | $13M | |
| Operating Expenses | $27M | $25M | $25M | $25M | $26M | $24M | $23M | $24M | $24M | $31M | $19M | $18M | $20M | $19M | $17M | $15M | |
| Operating Income | $-13M | $-12M | $-11M | $-12M | $-14M | $-13M | $-10M | $-13M | $-14M | $-22M | $-10M | $-10M | $-12M | $-12M | $-11M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $960.0K | · | $499.0K | $481.0K | $240.0K | $165.0K | $0 | |
| Other Non-op | $560.0K | $593.0K | $660.0K | $875.0K | $1M | $1M | $1M | $917.0K | $944.0K | $1M | $1M | $1M | $616.0K | $1M | $1M | $328.0K | |
| Pretax Income | $-14M | $-13M | $-12M | $-13M | $-15M | $-14M | $-11M | $-13M | $-14M | $-22M | $-9M | $-9M | $-12M | $-11M | $-11M | $-10M | |
| Income Tax | $3.0K | $1.0K | $-7.0K | $-3.0K | $-3.0K | $-5.0K | $-71.0K | $47.0K | $41.0K | $38.0K | $39.0K | $40.0K | $34.0K | $34.0K | $28.0K | $32.0K | |
| Net Income | $-14M | $-13M | $-12M | $-13M | $-15M | $-14M | $-11M | $-13M | $-14M | $-22M | $-9M | $-9M | $-12M | $-11M | $-11M | $-10M | |
| EPS (Basic) | $-0.53 | $-0.50 | $-0.45 | $-0.49 | $-0.57 | $-0.53 | $-0.39 | $-0.57 | $-0.65 | $-1.04 | $-0.45 | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | |
| EPS (Diluted) | $-0.53 | $-0.50 | $-0.45 | $-0.49 | $-0.57 | $-0.53 | $-0.39 | $-0.57 | $-0.65 | $-1.04 | $-0.45 | $-0.43 | $-0.56 | $-0.55 | $-0.51 | $-0.48 | |
| Shares (Basic) | 26,515,442 | 26,355,591 | · | 26,168,562 | 26,071,316 | 25,876,062 | · | 22,783,337 | 21,628,542 | 21,232,009 | · | 20,801,350 | 20,711,850 | 20,693,224 | · | 20,576,838 | |
| Shares (Diluted) | 26,515,442 | 26,355,591 | · | 26,168,562 | 26,071,316 | 25,876,062 | · | 22,783,337 | 21,628,542 | 21,232,009 | · | 20,801,350 | 20,711,850 | 20,693,224 | · | 20,576,838 | |
| EBITDA | $-13M | $-12M | · | $-12M | $-14M | $-13M | · | $-13M | $-14M | $-22M | · | $-10M | $-12M | $-12M | · | $-10M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $72M | $76M | $85M | $95M | $103M | $106M | $100M | $70M | $80M | $91M | $83M | $91M | $103M | $106M | $110M | |
| Receivables | $9M | $9M | $11M | $8M | $7M | $9M | $9M | $9M | $9M | $8M | $8M | $6M | $7M | $6M | $6M | $5M | |
| Inventory | $13M | $12M | $12M | $11M | $12M | $12M | $12M | $12M | $11M | $11M | $11M | $11M | $11M | $8M | $7M | $6M | |
| Prepaid Expense | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $4M | $3M | $4M | $3M | |
| Current Assets | $89M | $97M | $102M | $108M | $116M | $126M | $130M | $124M | $92M | $102M | $112M | $104M | $112M | $121M | $123M | $124M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $3M | $3M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $27.0K | $26.0K | $26.0K | $26.0K | $27.0K | $26.0K | $27.0K | $27.0K | $27.0K | $26.0K | |
| Total Assets | $92M | $100M | $105M | $111M | $120M | $130M | $133M | $128M | $96M | $106M | $115M | $106M | $115M | $123M | $125M | $127M | |
| Accounts Payable | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | $2M | $1M | $3M | $2M | $2M | $1M | |
| Accrued Liabilities | $7M | $6M | $9M | $8M | $7M | $6M | $8M | $8M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Current Liabilities | $11M | $9M | $13M | $11M | $10M | $9M | $11M | $11M | $9M | $8M | $8M | $7M | $9M | $8M | $8M | $7M | |
| Capital Leases | $448.0K | $544.0K | $638.0K | $730.0K | $819.0K | $802.0K | $877.0K | $951.0K | $1M | $1M | $1M | $916.0K | $946.0K | $59.0K | $117.0K | $175.0K | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $960.0K | $885.0K | $815.0K | $805.0K | $761.0K | |
| Total Liabilities | $72M | $71M | $65M | $63M | $62M | $60M | $62M | $62M | $41M | $40M | $39M | $24M | $25M | $23M | $16M | $8M | |
| Total Debt | $59M | $58M | · | $49M | $49M | $49M | · | $49M | $29M | $29M | · | $14M | $14M | $14M | · | · | |
| Common Stock | $266.0K | $264.0K | $263.0K | $262.0K | $261.0K | $261.0K | $253.0K | $242.0K | $217.0K | $216.0K | $209.0K | $208.0K | $208.0K | $207.0K | $207.0K | $206.0K | |
| Retained Earnings | $-618M | $-604M | $-591M | $-579M | $-566M | $-551M | $-537M | $-527M | $-514M | $-500M | $-477M | $-468M | $-459M | $-448M | $-436M | $-426M | |
| AOCI | $-204.0K | $-203.0K | $-203.0K | $-204.0K | $-203.0K | $-205.0K | $-206.0K | $-208.0K | $-210.0K | $-210.0K | $-207.0K | $-208.0K | $-187.0K | $-204.0K | $-207.0K | $-219.0K | |
| Stockholders' Equity | $20M | $29M | $39M | $48M | $58M | $69M | $71M | $65M | $55M | $66M | $76M | $83M | $90M | $100M | $109M | $118M | |
| Liabilities + Equity | $92M | $100M | $105M | $111M | $120M | $130M | $133M | $128M | $96M | $106M | $115M | $106M | $115M | $123M | $125M | $127M | |
| Shares Outstanding | 26,641,597 | 26,428,767 | 26,311,607 | 26,193,733 | 26,145,951 | 26,051,992 | 25,324,684 | 24,203,658 | 21,712,357 | 21,593,173 | 20,879,199 | 20,813,612 | 20,750,910 | 20,708,940 | 20,663,736 | 20,578,963 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $11M | $2M | $2M | $1M | $2M | $1M | $929.0K | |
| Operating Cash Flow | $-9M | $-12M | $-10M | $-10M | $-8M | $-13M | $-8M | $-10M | $-10M | $-11M | $-8M | $-8M | $-13M | $-10M | $-11M | $-11M | |
| CapEx | $112.0K | $122.0K | $68.0K | $295.0K | $103.0K | $114.0K | $52.0K | $37.0K | $355.0K | $917.0K | $169.0K | $39.0K | $143.0K | $240.0K | $79.0K | $264.0K | |
| Investing Cash Flow | $-112.0K | $-122.0K | $-68.0K | $-295.0K | $-103.0K | $-114.0K | $-52.0K | $-37.0K | $-355.0K | $-917.0K | $-169.0K | $-39.0K | $-143.0K | $-240.0K | $-79.0K | $-264.0K | |
| Stock Issued | $739.0K | $-43.0K | $-179.0K | $-45.0K | $0 | $9M | $12M | $20M | $-1.0K | $547.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $-43.0K | · | · | · | $9M | · | · | · | $547.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $9M | $410.0K | $103.0K | $392.0K | $10M | $14M | $40M | $472.0K | $1M | $16M | $363.0K | $473.0K | $8M | $7M | $7.0K | |
| Net Change in Cash | $-8M | $-3M | $-9M | $-10M | $-8M | $-3M | $6M | $30M | $-10M | $-10M | $8M | $-8M | $-12M | $-3M | $-4M | $-11M | |
| Free Cash Flow | · | $-12M | · | · | · | $-13M | · | · | · | $-12M | · | · | · | $-10M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $-11M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 87.4% | 87.2% | · | 86.8% | 84.3% | 83.5% | · | 83.2% | 83.9% | 85.0% | · | 83.9% | 84.0% | 83.4% | · | 78.3% | |
| Operating Margin | -82.9% | -82.3% | · | -83.5% | -105.8% | -108.8% | · | -97.3% | -118.3% | -206.4% | · | -90.6% | -123.7% | -152.4% | · | -163.7% | |
| Net Margin | -89.4% | -88.8% | · | -87.6% | -108.4% | -111.5% | · | -98.0% | -118.8% | -206.0% | · | -85.7% | -122.6% | -142.6% | · | -158.9% | |
| Pretax Margin | -89.4% | -88.8% | · | -87.6% | -108.5% | -111.5% | · | -97.6% | -118.5% | -205.7% | · | -85.4% | -122.3% | -142.1% | · | -158.4% | |
| EBITDA Margin | -82.9% | -82.3% | · | -83.5% | -105.8% | -108.8% | · | -97.3% | -118.3% | -206.4% | · | -90.6% | -123.7% | -152.4% | · | -163.7% | |
| ROA | -13.3% | -11.4% | · | -10.8% | -13.7% | -11.7% | · | -11.2% | -13.3% | -19.4% | · | -7.7% | -9.4% | -8.5% | · | -6.4% | |
| ROE | -36.1% | -26.7% | · | -22.7% | -26.0% | -20.3% | · | -17.7% | -19.3% | -26.8% | · | -9.0% | -10.7% | -9.6% | · | -7.2% | |
| ROIC | -16.6% | -13.9% | · | -12.6% | -13.4% | -11.3% | · | -11.4% | -16.6% | -23.3% | · | -9.8% | -11.3% | -10.7% | · | -8.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 10.2 | · | 9.6 | 12.0 | 14.8 | · | 11.3 | 10.1 | 12.2 | · | 14.0 | 12.6 | 15.2 | · | 16.8 | |
| Quick Ratio | 6.7 | 8.6 | · | 8.3 | 10.5 | 13.1 | · | 10.0 | 8.7 | 10.6 | · | 12.1 | 10.9 | 13.8 | · | 15.6 | |
| Debt / Equity | 2.9 | 2.0 | · | 1.0 | 0.9 | 0.7 | · | 0.8 | 0.5 | 0.4 | · | 0.2 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | 2.9 | 2.0 | · | 1.0 | 0.9 | 0.7 | · | 0.8 | 0.5 | 0.4 | · | 0.2 | 0.2 | 0.1 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -23.2 | · | -19.1 | -24.4 | -50.7 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.9 | 1.6 | · | 1.7 | 1.7 | 1.4 | · | 1.7 | 1.5 | 1.4 | · | 1.8 | 1.8 | 1.6 | · | 1.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.75 | $1.10 | · | $1.83 | $2.22 | $2.66 | · | $2.69 | $2.54 | $3.07 | · | $3.98 | $4.34 | $4.81 | · | $5.75 | |
| Revenue / Share | $0.59 | $0.56 | · | $0.56 | $0.52 | $0.48 | · | $0.59 | $0.55 | $0.51 | · | $0.51 | $0.46 | $0.39 | · | $0.30 | |
| Cash Flow / Share | · | $-0.46 | · | · | · | $-0.49 | · | · | · | $-0.51 | · | · | · | $-0.50 | · | · | |
| Cash / Share | $2.42 | $2.74 | · | $3.25 | $3.63 | $3.94 | · | $4.14 | $3.24 | $3.71 | · | $3.99 | $4.38 | $4.99 | · | $5.34 | |
| EPS (TTM) | $-1.97 | $-2.01 | · | $-1.98 | $-2.06 | $-2.14 | · | $-2.71 | $-2.57 | $-2.48 | · | $-2.05 | $-2.10 | $-2.08 | · | $67.03 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $61M | $59M | · | $56M | $55M | $53M | · | $47M | $44M | $42M | · | $35M | $31M | $26M | · | $19M | |
| Net Income TTM | $-52M | $-53M | · | $-52M | $-52M | $-52M | · | $-58M | $-54M | $-52M | · | $-43M | $-43M | $-43M | · | $-41M | |
| Market Cap | $137M | $250M | · | $211M | $154M | $319M | · | $213M | $260M | $393M | · | $316M | $320M | $193M | · | $192M | |
| Enterprise Value | $131M | $236M | · | $176M | $108M | $265M | · | $162M | $219M | $342M | · | $247M | $244M | $104M | · | · | |
| P/E | -2.6 | -4.7 | · | -4.1 | -2.9 | -5.7 | · | -3.3 | -4.7 | -7.3 | · | -7.4 | -7.4 | -4.5 | · | 0.1 | |
| P/S | 2.2 | 4.2 | · | 3.8 | 2.8 | 6.0 | · | 4.5 | 5.9 | 9.3 | · | 9.0 | 10.4 | 7.3 | · | 10.1 | |
| P/B | 6.9 | 8.6 | · | 4.4 | 2.7 | 4.6 | · | 3.3 | 4.7 | 5.9 | · | 3.8 | 3.6 | 1.9 | · | 1.6 | |
| P / Tangible Book | 6.9 | 8.6 | · | 4.4 | 2.7 | 4.6 | · | 3.3 | 4.7 | 5.9 | · | 3.8 | 3.6 | 1.9 | · | 1.6 | |
| P / Cash Flow | · | -20.6 | · | · | · | -25.0 | · | · | · | -36.1 | · | · | · | -18.8 | · | · | |
| EV / Revenue | 2.1 | 4.0 | · | 3.1 | 2.0 | 5.0 | · | 3.4 | 4.9 | 8.1 | · | 7.0 | 7.9 | 3.9 | · | · | |
| Earnings Yield | -38.3% | -21.2% | · | -24.5% | -35.0% | -17.5% | · | -30.8% | -21.4% | -13.6% | · | -13.5% | -13.6% | -22.3% | · | 718.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $57M | $51M | $39M | $22M | $13M |
| Bruttogewinnmarge % | 85.3% | 83.8% | 84.1% | 77.8% | 72.1% |
| Betriebsgewinnmarge % | -90.5% | -116.0% | -109.7% | -189.3% | -199.2% |
| Nettoergebnis | $-53M | $-60M | $-41M | $-41M | $-43M |
| Verwässerte EPS | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 1.3 | 0.7 | 0.4 | 0.1 | 0.0 |
| Liquiditätsgrad | 7.6 | 12.1 | 14.3 | 15.2 | 25.6 |
| Quick Ratio | 6.5 | 10.7 | 12.5 | 13.8 | 24.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-41M | $-41M | $-40M | $-43M | $-29M |
Institutionelle Eigentümer (13F) 95 Einreicher · $87.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
95
Gehaltener Wert
$87.3M
Neue Positionen
8
Geschlossene Positionen
18
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 8 (-19 vs. Vorquartal) | 18 (+5 vs. Vorquartal) | 35 (+2 vs. Vorquartal) | 29 (+9 vs. Vorquartal) | +574K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| JOHNSON & JOHNSON | $20.687.786 | 4.024.861 | 23,70% | Aktien |
| NEA Management Company, LLC | $10.045.822 | 1.954.440 | 11,51% | Aktien |
| VANGUARD GROUP INC | $7.956.707 | 1.120.663 | 9,12% | Aktien |
| BlackRock, Inc. | $6.401.661 | 1.245.459 | 7,33% | Aktien |
| ROYAL BANK OF CANADA | $6.338.000 | 1.233.212 | 7,26% | Aktien |
| GSK plc | $5.178.977 | 1.007.583 | 5,93% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.680.361 | 910.576 | 5,36% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $4.513.480 | 878.109 | 5,17% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $2.266.478 | 440.786 | 2,60% | Aktien |
| PFM Health Sciences, LP | $1.899.600 | 369.572 | 2,18% | Aktien |
| STATE STREET CORP | $1.883.049 | 366.352 | 2,16% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.182.200 | 230.000 | 1,35% | Aktien |
| UBS Group AG | $1.152.558 | 224.233 | 1,32% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $1.057.216 | 205.684 | 1,21% | Aktien |
| GOLDMAN SACHS GROUP INC | $768.476 | 149.509 | 0,88% | Aktien |
| MORGAN STANLEY | $745.182 | 144.977 | 0,85% | Aktien |
| Kestra Advisory Services, LLC | $680.536 | 132.400 | 0,78% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $680.526 | 132.398 | 0,78% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $662.829 | 128.955 | 0,76% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $659.866 | 127.971 | 0,76% | Aktien |
| NORTHERN TRUST CORP | $641.302 | 124.767 | 0,73% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $544.403 | 105.915 | 0,62% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $542.856 | 105.614 | 0,62% | Aktien |
| Cresset Asset Management, LLC | $533.784 | 103.849 | 0,61% | Aktien |
| AlphaQuest LLC | $502.645 | 70.795 | 0,58% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $500.168 | 97.309 | 0,57% | Aktien |
| Quantinno Capital Management LP | $423.192 | 82.333 | 0,48% | Aktien |
| CITADEL ADVISORS LLC | $406.127 | 79.013 | 0,47% | Aktien |
| Jump Financial, LLC | $398.350 | 77.500 | 0,46% | Aktien |
| Nuveen, LLC | $254.666 | 49.546 | 0,29% | Aktien |
| WOLVERINE TRADING, LLC | $228.312 | 29.346 | 0,26% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $220.986 | 23.360 | 0,25% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $210.226 | 40.900 | 0,24% | Aktien |
| Bank of New York Mellon Corp | $198.641 | 38.646 | 0,23% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $181.946 | 35.398 | 0,21% | Aktien |
| Point72 Asset Management, L.P. | $137.613 | 26.773 | 0,16% | Aktien |
| XTX Topco Ltd | $112.181 | 21.825 | 0,13% | Aktien |
| JPMORGAN CHASE & CO | $109.932 | 18.507 | 0,13% | Aktien |
| Jain Global LLC | $109.482 | 21.300 | 0,13% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $106.532 | 20.726 | 0,12% | Aktien |
| RBF Capital, LLC | $102.800 | 20.000 | 0,12% | Aktien |
| BANK OF AMERICA CORP /DE/ | $102.085 | 19.861 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $96.688 | 18.812 | 0,11% | Aktien |
| WELLS FARGO & COMPANY/MN | $85.797 | 16.692 | 0,10% | Aktien |
| Corton Capital Inc. | $85.461 | 10.590 | 0,10% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $84.476 | 16.435 | 0,10% | Aktien |
| Graham Capital Management, L.P. | $76.884 | 14.958 | 0,09% | Aktien |
| CWM, LLC | $76.238 | 8.059 | 0,09% | Aktien |
| JANE STREET GROUP, LLC | $69.390 | 13.500 | 0,08% | Kaufoption |
| R Squared Ltd | $68.907 | 13.406 | 0,08% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Chernett Jorey ×2 Einreichungen | 2. Oktober 2026 | 0,62% | Änderung | · | SEC |
| New Enterprise Associates 10, Limited Partnership, New Enterprise Associates 8A, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell | 20. Februar 2025 | 7,80% | Änderung | · | SEC |
| Cooperatieve Gilde Healthcare IV U.A., Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V., Manapouri B.V., Martemanshurk B.V. ×4 Einreichungen | 6. Februar 2025 | 4,90% | Änderung | · | SEC |
| New Enterprise Associates 8A, Limited Partnership, New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 Einreichungen | 7. November 2024 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 25 Insider · 11 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kevin Hykes | PRES & CEO | 27. Februar 2026 A | 284.237 | 0 | 1 | $-61.328 |
| Nadim Yared | CHIEF EXECUTIVE OFFICER | 2. Februar 2024 A | 26.255 | 0 | 0 | $0 |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | 27. Februar 2026 A | 96.703 | 0 | 1 | $-13.778 |
| Brent Binkowski | CHIEF OPERATING OFFICER | 13. August 2026 P | 56.514 | 1 | 1 | $72.971 |
| Philip B. Adamson | Chief Medical Officer | 27. Februar 2026 A | 61.578 | 0 | 1 | $-9.970 |
| Robert Allen John | Chief Revenue Officer | 27. Februar 2026 A | 86.036 | 0 | 1 | $-31.316 |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | 27. Februar 2026 A | 60.551 | 0 | 1 | $-10.144 |
| Craig E. Palmer | SVP, U.S. SALES | 25. März 2024 M | 1.229 | 0 | 0 | $0 |
| Liz Galle | VP OF GLOBAL CLINICAL RESEARCH | 16. Oktober 2023 M | 778 | 0 | 0 | $0 |
| Dean Bruhn-Ding | VP OF REG. AFFAIRS AND QA | 2. August 2022 A | 54.648 | 0 | 0 | $0 |
| John Brintnall | CHIEF STRATEGY OFFICER AND SEC | 22. April 2022 M | 21.901 | 0 | 0 | $0 |
| Martha Shadan | Direktor | 1. Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Mitch C. Hill, | Direktor | 1. Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Mudit K. Jain | Direktor | 1. Juni 2026 A | 14.370 | 2 | 0 | $300.432 |
| Kevin J. Ballinger | Direktor | 1. Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Kirk Nielsen | Direktor | 1. Juni 2026 A | 8.720 | 0 | 0 | $0 |
| Ali Behbahani | Direktor | 4. Juni 2024 A | 316 | 0 | 0 | $0 |
| John M Nehra | Direktor | 7. Juni 2022 A | 28.266 | 0 | 0 | $0 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10%-Eigentümer | 15. September 2023 J | 0 | 0 | 0 | $0 |
| New Enterprise Associates 10, Limited Partnership | 10%-Eigentümer | 2. Juli 2021 C | 2.026.083 | 0 | 0 | $0 |
| Joseph P Slattery | · | 1. Juni 2026 A | 39.365 | 0 | 0 | $0 |
| DALE MICHAEL D | · | 1. Juni 2026 A | 29.005 | 0 | 0 | $0 |
| Gregory Morrison | · | 2. März 2026 A | 34.000 | 0 | 0 | $0 |
| Geoffrey B Pardo | · | 2. Juli 2021 C | 1.829.022 | 0 | 0 | $0 |
| GSK plc | · | 2. Juli 2021 C | 1.007.583 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 14 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 51.258 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,00% | 156.004 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,00% | 7.352 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 364.840 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 28.363 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.354 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 5.299 SH | 3. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 5.367 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 204.533 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 684.121 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 89.003 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 15.722 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.190 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 31. Juli 2026 | N-PORT |
CVRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$4.50
+190,3%
3 23,1%
Starker Kauf
6 46,2%
Kauf
3 23,1%
Halten
1 7,7%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-10-03Mittelwert-Ziel $4.58 +195,7%
← Unter allen Zielen
Aktueller Preis $1.55
Tief$3.50
Mittelwert$4.58
Hoch$6.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CVRX | $187M | -3.5 | 10.4% | -94.1% | -109.6% | 85.3% |
| MDAI | · | · | · | · | · | · |
| ODYS | $54M | -3.1 | -23.9% | -565.0% | -58.7% | 28.9% |
| SRTS | $66M | -8.5 | -34.3% | -28.1% | -15.4% | 43.2% |
| POCI | $56M | -11.9 | 65.2% | -11.5% | -24.5% | 17.2% |
| SNWV | $256M | 72.8 | 35.0% | 26.8% | -395.5% | 77.1% |
| QTI | $73M | -3.0 | 287.9% | -111.4% | -688.9% | 45.4% |
| ARAY | $31M | -0.9 | -12.3% | -12.2% | -103.4% | 27.7% |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026